12:00 AM
Apr 29, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

SIR-Spheres: Completed Phase III enrollment

Sirtex completed enrollment of over 500 patients in the international Phase III SIRFLOX trial to evaluate SIR-Spheres plus FOLFOX6 (5-FU, leucovorin, and oxaliplatin) vs. FOLFOX6 alone. The product...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >